Previous studies have suggested that PLOD2 is overexpressed in sarcoma [20], bladder cancer [16], renal cell carcinoma [21], glioblastoma [24], cervical cancer [25], oral carcinoma [17], bone metastasis [26] and other types of cancers [15]. The gene discussed is PLOD2; the disease is renal cell carcinoma.